Keymed Biosciences Inc. Stock
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
04:08:27 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 81.55 HKD | +2.45% |
|
+3.89% | +52.57% |
| Market Cap | 20.54B 24.05B 3.07B 2.72B 2.54B 2.32B 4.35B 295B 4.43B 30.74B 11.91B 150B 11.51B 11.26B 484B | P/E 2026 * |
25.5x | P/E 2027 * | 1,434x |
|---|---|---|---|---|---|
| Enterprise Value | 19.41B 22.74B 2.9B 2.57B 2.4B 2.19B 4.11B 279B 4.18B 29.06B 11.26B 142B 10.88B 10.64B 458B | EV / Sales 2026 * |
11.5x | EV / Sales 2027 * | 9.13x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | +2.45% | ||
| 1 week | +3.89% | ||
| 1 month | +8.66% | ||
| 3 months | +15.27% | ||
| 6 months | +34.35% | ||
| Current year | +52.57% |
| 1 week | 72.3 |  | 82.4 |
| 1 month | 71 | | 82.4 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 2018-04-22 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 2021-03-02 |
Pak Yu Tam
SEC | Corporate Secretary | - | 2022-03-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 2018-04-22 |
Changyu Wang
BRD | Director/Board Member | 61 | 2021-03-02 |
Gang Xu
BRD | Director/Board Member | 52 | 2018-06-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/13/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 6/11/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 9/15/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.45% | +3.89% | +9.83% | +63.43% | 3.06B | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -2.67% | +37.26% | +32.51% | 44.25B | |
| +0.31% | +7.94% | +340.88% | +643.82% | 43.99B | |
| -1.96% | -1.71% | +5.30% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -8.24% | -24.60% | +330.06% | 24.93B | |
| Average | +0.20% | +2.16% | +50.87% | +145.19% | 39.99B | |
| Weighted average by Cap. | +0.19% | +1.85% | +59.68% | +145.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68B 1.97B 251M 223M 208M 190M 356M 24.18B 362M 2.52B 975M 12.32B 943M 922M 39.68B | 2.15B 2.51B 320M 284M 266M 242M 455M 30.85B 462M 3.21B 1.24B 15.72B 1.2B 1.18B 50.63B |
| Net income | 672M 788M 100M 89.11M 83.26M 75.92M 142M 9.67B 145M 1.01B 390M 4.92B 377M 369M 15.86B | -14.18M -16.6M -2.12M -1.88M -1.76M -1.6M -3M -204M -3.05M -21.22M -8.22M -104M -7.95M -7.77M -334M |
| Net Debt | -1.12B -1.32B -168M -149M -139M -127M -238M -16.15B -242M -1.68B -651M -8.22B -629M -616M -26.49B | -935M -1.1B -140M -124M -116M -106M -198M -13.44B -201M -1.4B -542M -6.85B -524M -513M -22.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | HK$81.55 | +2.45% | 2,630,600 |
| 26-09-29 | HK$79.60 | +8.82% | 4,260,252 |
| 26-09-28 | HK$73.15 | -2.40% | 2,244,500 |
| 26-09-25 | HK$74.95 | +1.22% | 600,500 |
| 26-09-24 | HK$74.05 | -5.67% | 1,392,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
